We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Prescription drug prices increased by more than three times the rate of inflation between 2008 and 2017, according to a new analysis that accounts for rebates and discounts. Read More
The FDA released final guidance yesterday on the transition of insulin and other biological products from new drug applications (NDAs) to biologics license applications (BLAs) as the March 23 transition date looms. Read More
The FDA issued a warning letter to over-the-counter drugmaker Essnd Global for serious GMP deficiencies at its facility in Maharashtra, India. Read More
Connecticut-based online pharmacy Valisure has petitioned the FDA to recall specific batches of the type 2 diabetes drug metformin from numerous manufacturers because it found high levels of N-Nitrosodimethylamine (NDMA) in the products. Read More
The Department of Justice filed suit against Mallinckrodt in a Massachusetts federal court yesterday for allegedly evading more than $250 million worth of Medicaid rebates for its H.P. Acthar Gel (repository corticotropin). Read More
FDA Commissioner Stephen Hahn told Congress yesterday that India is restricting exports of 13 active pharmaceutical ingredients (API) and the drug formulations made from them to protect its internal supply chain. Read More